3.1 Diagnostic Endoscopy (EGD & Colonoscopy)
Key Takeaways
- Esophagogastroduodenoscopy (EGD) evaluates the esophagus, stomach, and duodenum; colonoscopy evaluates the entire colon to the cecum and frequently the terminal ileum.
- The 2024 ASGE/ACG adenoma detection rate (ADR) target rose to at least 35% overall (40% men, 30% women); each 1% rise in ADR lowers interval colorectal cancer risk about 3%.
- Average-risk colorectal cancer screening starts at age 45, with a 10-year interval after a complete, adequately prepped normal colonoscopy.
- The 2024 minimum mean withdrawal time is at least 8 minutes on negative screening exams, and cecal intubation rate should reach at least 95%.
- Routine biopsies go into 10% neutral buffered formalin, labeled by exact anatomic site at the point of collection; Helicobacter pylori urease, cytology, and microbiology specimens are handled differently.
Why Diagnostic Endoscopy Dominates the Exam
Diagnostic endoscopy is the foundation of the largest content domain on the Certified Gastroenterology Registered Nurse (CGRN) exam. A typical GI unit performs far more diagnostic esophagogastroduodenoscopies (EGDs) and colonoscopies than any other procedure, so the test expects you to know indications, the nursing role at every phase, and the quality metrics that separate a complete exam from a missed lesion.
An EGD is direct visualization of the esophagus, stomach, and duodenum with a forward-viewing flexible upper endoscope (working length ~100 cm). A colonoscopy visualizes the rectum, entire colon, and frequently the terminal ileum with a longer colonoscope (~160-170 cm). Both are typically performed under moderate or deep sedation in roughly 15-45 minutes.
Indications
| Procedure | Common Indications | Classic Alarm Features |
|---|---|---|
| EGD | Dysphagia, refractory GERD, suspected peptic ulcer, upper GI bleeding, iron-deficiency anemia, Barrett surveillance, celiac biopsy | Weight loss, dysphagia, anemia, hematemesis, age >60 with new dyspepsia |
| Colonoscopy | Colorectal cancer (CRC) screening/surveillance, hematochezia, chronic diarrhea, iron-deficiency anemia, inflammatory bowel disease (IBD) assessment, abnormal imaging | Rectal bleeding, change in bowel habits, unexplained anemia, family history of CRC |
Gastroesophageal reflux disease (GERD) that fails 4-8 weeks of proton pump inhibitor therapy, the presence of alarm features, or surveillance of Barrett esophagus are classic EGD triggers. Colonoscopy is unique among CRC screening tests because it is simultaneously diagnostic and therapeutic — a polyp seen can be removed in the same session, which no stool-based or imaging test allows.
The Nursing Role Across Three Phases
The CGRN nurse owns three distinct phases. A common exam trap is assigning a task to the wrong phase (for example, treating discharge teaching as an intra-procedure duty).
- Pre-procedure: verify a signed, dated informed consent with a current procedure name; confirm bowel-prep completeness using the Boston Bowel Preparation Scale (BBPS); validate NPO status (commonly clear liquids until 2 hours before and solids stopped 6-8 hours before per ASA guidance); review anticoagulation, allergies, and prior sedation reactions; establish IV access; and complete a pre-sedation assessment including airway (Mallampati) and ASA physical-status class.
- Intra-procedure: continuous monitoring of oxygenation (SpO2), ventilation (capnography is the standard of care for moderate and deep sedation), blood pressure, heart rate, ECG, and level of consciousness; airway and positioning management (left lateral for both EGD and colonoscopy); accessory and device handling; and real-time documentation of medications, doses, times, and vital signs.
- Post-procedure: monitor to objective discharge criteria (often a modified Aldrete score), watch for perforation and bleeding (severe or worsening abdominal pain, distension, fever, tachycardia, hematemesis, melena), and provide written discharge teaching released only to a responsible adult driver because residual sedation impairs judgment for the rest of the day.
Biopsy and Specimen Handling
Specimen integrity is a high-yield, frequently tested topic because a mishandled specimen can require a repeat procedure and re-sedation.
- Use the correct container and fixative: most biopsies go into 10% neutral buffered formalin. Specimens for Helicobacter pylori rapid urease testing, cytology, microbiology/culture, or molecular studies are NOT placed in formalin and follow protocol-specific media.
- Label at the point of collection with two patient identifiers and the exact anatomic site ("gastric antrum" versus "gastric body," or "sigmoid colon" versus "cecum").
- Keep multi-site biopsies in separate, individually labeled containers so the pathologist can localize disease.
- Perform a specimen time-out confirming count, site, and labeling with the endoscopist before the patient leaves the room.
2024 Quality Metrics (Updated)
In 2024 the ASGE/ACG task force raised the colonoscopy quality benchmarks. Know both the new targets and that higher ADR is the metric most tied to outcomes.
| Metric | 2024 Benchmark | Prior Target | Why It Matters |
|---|---|---|---|
| Cecal intubation rate | ≥ 95% | ≥ 90% all / ≥ 95% screening | Confirms a complete exam (photo of appendiceal orifice / ileocecal valve) |
| Withdrawal time | ≥ 8 minutes (negative screening, age 45+) | ≥ 6 minutes | Longer inspection finds more adenomas |
| Adenoma detection rate (ADR) | ≥ 35% overall (40% men, 30% women) | ≥ 25% (30%/20%) | Each 1% rise in ADR ≈ 3% lower interval-cancer risk |
| Bowel prep adequacy | ≥ 90% of exams adequate | ≥ 85% | Inadequate prep misses lesions and shortens intervals |
The nurse contributes by reinforcing split-dose prep instructions, documenting BBPS prep quality, and recording withdrawal and cecal-landmark photos for the procedure record.
Screening and Surveillance Intervals (USMSTF 2020)
- Average-risk CRC screening begins at age 45 and continues to 75 (selective 76-85).
- A complete, adequately prepped normal colonoscopy is repeated in 10 years.
- 1-2 small (<10 mm) tubular adenomas: repeat in 7-10 years (extended from 5-10 in the 2020 USMSTF update).
- Advanced adenoma (≥10 mm, villous histology, or high-grade dysplasia) or 3-4 adenomas: repeat in 3 years.
- 5-10 adenomas: repeat in 3 years; piecemeal resection of a ≥20 mm lesion warrants a 6-month check.
- Every interval assumes a complete exam with adequate prep; inadequate prep shortens the interval, usually to within 1 year.
During a screening colonoscopy on an average-risk patient, the endoscopist documents that the cecum was reached, the bowel prep was adequate, and no polyps were found. When should the next screening colonoscopy normally be scheduled?
A nurse is documenting endoscopy quality data using the current 2024 ASGE/ACG benchmarks. Which finding meets the updated overall adenoma detection rate (ADR) target?
The endoscopist takes biopsies from the gastric antrum and the gastric body during an EGD. What is the most appropriate specimen-handling action?